Peter W. Nagle

622 total citations
16 papers, 450 citations indexed

About

Peter W. Nagle is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Peter W. Nagle has authored 16 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Peter W. Nagle's work include Cancer Cells and Metastasis (5 papers), Effects of Radiation Exposure (3 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Peter W. Nagle is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Effects of Radiation Exposure (3 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Peter W. Nagle collaborates with scholars based in Netherlands, United Kingdom and Germany. Peter W. Nagle's co-authors include Robert P. Coppes, Peter van Luijk, John Th. M. Plukker, Christina T. Muijs, Johannes A. Langendijk, S. Brandenburg, Hette Faber, Roland K. Chiu, Nynke A. Hosper and Rudolf A. de Boer and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Peter W. Nagle

16 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter W. Nagle Netherlands	11	174	140	101	88	85	16	450
Mohammed Rashid United Kingdom	9	237 1.4×	173 1.2×	83 0.8×	62 0.7×	25 0.3×	15	526
Zhi Dong China	16	153 0.9×	79 0.6×	204 2.0×	85 1.0×	50 0.6×	48	611
Wen Wei China	13	262 1.5×	166 1.2×	86 0.9×	111 1.3×	30 0.4×	21	551
Katherine J. Blair United States	11	128 0.7×	138 1.0×	67 0.7×	55 0.6×	43 0.5×	17	389
Stephen Raskin Israel	10	157 0.9×	243 1.7×	83 0.8×	84 1.0×	42 0.5×	31	607
Alexander Meisel Switzerland	12	183 1.1×	147 1.1×	96 1.0×	102 1.2×	13 0.2×	27	486
Reza Golestani United States	15	65 0.4×	92 0.7×	111 1.1×	165 1.9×	34 0.4×	27	444
Wei Geng China	9	162 0.9×	213 1.5×	81 0.8×	188 2.1×	25 0.3×	26	604
Megumi Takehara Japan	13	130 0.7×	74 0.5×	49 0.5×	72 0.8×	22 0.3×	31	468

Countries citing papers authored by Peter W. Nagle

Since Specialization

Citations

This map shows the geographic impact of Peter W. Nagle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Nagle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Nagle more than expected).

Fields of papers citing papers by Peter W. Nagle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter W. Nagle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Nagle. The network helps show where Peter W. Nagle may publish in the future.

Co-authorship network of co-authors of Peter W. Nagle

This figure shows the co-authorship network connecting the top 25 collaborators of Peter W. Nagle. A scholar is included among the top collaborators of Peter W. Nagle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter W. Nagle. Peter W. Nagle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Furqan, Muhammad, Richard Elliott, Peter W. Nagle, et al.. (2025). Drug Combinations Targeting FAK and MEK Overcomes Tumor Heterogeneity in Glioblastoma. Pharmaceutics. 17(5). 549–549. 2 indexed citations

Furqan, Muhammad, Richard Elliott, Peter W. Nagle, et al.. (2024). P06.09.B RATIONAL DRUG COMBINATIONS TARGETING FAK AND MEK OVERCOMES TUMOUR HETEROGENEITY IN GLIOBLASTOMA. Neuro-Oncology. 26(Supplement_5). v45–v45. 1 indexed citations

Culley, Jayne, Peter W. Nagle, John C. Dawson, & Neil O. Carragher. (2022). Patient derived glioma stem cell spheroid reporter assays for live cell high content analysis. SLAS DISCOVERY. 28(2). 13–19. 2 indexed citations

Wang, Da, Peter W. Nagle, Hao Zhang, et al.. (2022). Role of mTOR through Autophagy in Esophageal Cancer Stemness. Cancers. 14(7). 1806–1806. 5 indexed citations

Hosper, Nynke A., Peter W. Nagle, Julia Heß, et al.. (2021). Generation and Differentiation of Adult Tissue-Derived Human Thyroid Organoids. Stem Cell Reports. 16(4). 913–925. 50 indexed citations

Nagle, Peter W. & Robert P. Coppes. (2020). Current and Future Perspectives of the Use of Organoids in Radiobiology. Cells. 9(12). 2649–2649. 21 indexed citations

Nagle, Peter W., Marc‐Jan van Goethem, Antje Knopf, et al.. (2019). In vitro biological response of cancer and normal tissue cells to proton irradiation not affected by an added magnetic field. Radiotherapy and Oncology. 137. 125–129. 8 indexed citations

Wang, Da, Peter W. Nagle, Justin K. Smit, et al.. (2019). Hedgehog Pathway as a Potential Intervention Target in Esophageal Cancer. Cancers. 11(6). 821–821. 18 indexed citations

Nagle, Peter W., John Th. M. Plukker, Christina T. Muijs, Peter van Luijk, & Robert P. Coppes. (2018). Patient-derived tumor organoids for prediction of cancer treatment response. Seminars in Cancer Biology. 53. 258–264. 126 indexed citations

10.

Nagle, Peter W., Nynke A. Hosper, Lara Barazzuol, et al.. (2018). Lack of DNA Damage Response at Low Radiation Doses in Adult Stem Cells Contributes to Organ Dysfunction. Clinical Cancer Research. 24(24). 6583–6593. 33 indexed citations

11.

Nagle, Peter W., Nynke A. Hosper, Marc‐Jan van Goethem, et al.. (2016). The In Vitro Response of Tissue Stem Cells to Irradiation With Different Linear Energy Transfers. International Journal of Radiation Oncology*Biology*Physics. 95(1). 103–111. 26 indexed citations

12.

Ghobadi, Ghazaleh, Rudolf A. de Boer, Hette Faber, et al.. (2014). ACE inhibition attenuates radiation-induced cardiopulmonary damage. Radiotherapy and Oncology. 114(1). 96–103. 93 indexed citations

13.

Chiu, Roland K., Peter W. Nagle, Lonneke C. Wilms, et al.. (2013). Genetic polymorphisms in catalase and CYP1B1 determine DNA adduct formation by benzo(a)pyrene ex vivo. Mutagenesis. 28(2). 181–185. 14 indexed citations

14.

Niemantsverdriet, Maarten, Peter W. Nagle, Roland K. Chiu, et al.. (2012). ΔNp73 Enhances Promoter Activity of TGF-β Induced Genes. PLoS ONE. 7(12). e50815–e50815. 17 indexed citations

15.

Nagle, Peter W., Sander S. Rensen, Roger Godschalk, et al.. (2011). Decreased nucleotide excision repair in steatotic livers associates with myeloperoxidase-immunoreactivity. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 736(1-2). 75–81. 24 indexed citations

16.

Knobloch, William H., Peter W. Nagle, C. L. Shetlar, & M. R. Shetlar. (1952). Effect of Epidermal Damage upon Serum Polysaccharides. Experimental Biology and Medicine. 81(2). 417–420. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact